A cross sectional analysis of medical device associated adverse events with radiotherapy devices - A materiovigilance study.

Autor:	Raghav MV; Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India., Geetha A; Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India., Purushotham VS; Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India., Mamatha K; Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India., Rajesh J; Department of Radiotherapy, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India., Raghuvanshi R; Drugs Controller General of India Indian Pharmacopoeia Commission, India., Kalaiselvan V; Drugs Controller General of India Indian Pharmacopoeia Commission, India., Shukla S; Drugs Controller General of India Indian Pharmacopoeia Commission, India., Hariharan V; Drugs Controller General of India Indian Pharmacopoeia Commission, India., Gowda BN; Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
Jazyk:	angličtina
Zdroj:	Indian journal of pharmacology [Indian J Pharmacol] 2023 May-Jun; Vol. 55 (3), pp. 162-166.
DOI:	10.4103/ijp.ijp_818_22
Abstrakt:	Background: Materiovigilance is a method for tracking, documenting, and analyzing the causal factors of adverse outcomes or complications associated with the use of medical devices. In addition, it recommends that the Indian regulatory authority takes necessary steps with the aim of enhancing patient safety. The present study was taken up as there are hardly any studies available in the public domain on adverse events due to radiotherapy. Objective: The objective of the study is to analyze the pattern of adverse events due to medical devices used in the department of radiation oncology. Methods: It was a cross-sectional study carried out from June to September, 2022. The patients who were treated with the medical devices in radiation oncology at Victoria Hospital affiliated with Bangalore Medical College and Research Institute, Bengaluru, were included. The medical device used on the patients causes adverse events. The data were collected from the patient's health records available in the department of radiotherapy. Results: Total 40 adverse events collected as per inclusion and exclusion criteria were analyzed. All the adverse events associated with medical devices were filled in the medical device adverse event reporting form and submitted to materiovigilance program, which also included the causality assessment. All the adverse events were caused due to external beam radiotherapy/teletherapy device. Dermatitis was the most common adverse event found in the reported cases (n = 20, 50%). Conclusion: Materiovigilance program is in budding stage. It was observed that the adverse events in patients were due to medical devices used in radiation oncology. Medical devices with skin-sparing effect (radiation is converged onto tumor) should be promoted and more research and engineering are required in designing of advanced medical devices for the treatment of cancer across the globe. Competing Interests: None
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF